Assistant Professor Tingyi “Leo” Liu is one member of an international team of researchers from UMass Amherst, the University of California at Los Angeles (UCLA), and universities in China and Singapore that is using artificial intelligence to develop a system that minimizes the dosage of drugs used to treat human immunodeficiency virus (HIV) as a way to reduce side effects. Liu is the head of the Interdisciplinary Interface Engineering Laboratory in the College of Engineering. The findings are published in the journal Advanced Therapeutics. See Science Blog and News Office release. (January 2020)